Developing a novel adolescent cardiovascular health promotion program (CPP)

Active Project Grant Awarded Last action

Award ID
R34HL171722
Recipient
Awarding agency
Obligated
$1,247,122

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 88% complete
Place of performance
Chicago, IL 60611, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Cardiovascular disease (CVD) risk factors in adolescence are common and robustly associated with adult CVD events. Clinical capacity for intensive behavioral intervention is insufficient to meet demand, and moreover, standard behavioral interventions have had limited efficacy in adolescents. Pediatric guidelines identify critical gaps: we need more effective adolescent interventions, with a greater focus on CVD risk factors beyond BMI, and we need to build lean, effective and scalable treatment packages using the multiphase optimization strategy (most). In response, we propose to develop and pilot-test a novel cardiovascular health (CVH) promotion program (CPP) precisely tailored for adolescents with CVD risk factors. Our preparatory work systematically identified intervention components expected to be effective based on theory, evidence, and user preferences. We propose to overcome efficacy limitations of standard interventions by adding novel components to engage emotion and identity mechanisms of adolescent behavior. These core motivational mechanisms are highly sali- ENT in adolescence, which is marked by self-identity formation, heightened emotionality, and emotion regulation difficulties. Concurrently, we propose to overcome scalability issues through protocolized, remote, and largely self-guided delivery methods, based on our successful adult interventions. We will employ the most framework to systematically optimize CPP for efficacy while balancing the need for scalability. The current R34 will be the preparation phase of most, yielding refined intervention components and operational guidelines for the opti- mization-phase RCT. In aim 1, we will adapt and iteratively refine existing intervention content, including the diabetes prevention program for standard behavioral content, the unified protocol for transdiagnostic treat- ment of emotional disorders in adolescents for emotion regulation content, and academic interventions for iden- tity content. We will tailor content for the target population and adapt IT for remote delivery via self-guided videos and worksheets, brief 1:1 coaching, and group sessions. Our person-centered iterative design process will EN- gage adolescents to refine intervention prototypes and protocols via think-aloud/interview sessions, with further input from our teen and adult community advisory boards. In aim 2, we will randomize 42 adolescents with CVD risk factors to 1 of 3 arms in an 8-week pre-post pilot trial. Arms will vary 4 components added to standard behavioral content: emotion content (yes/no), identity content (yes/no), group sessions (yes/no), and coaching dose (high/low). The 3 arms will test conditions with the highest burden (all yes/high), lowest novelty (all no/low), and greatest contamination risk (mixed). Mixed quantitative/qualitative data will establish feasibility, acceptability, and fidelity against predefined benchmarks. This R34 will fully prepare US to conduct the optimization-phase factorial RCT and assemble 'active' components into a lean CPP package for evaluation-phase effectiveness testing. This work directly responds to nhlbi's calls (not-HL-21-020) and is expected to ultimately produce a scalable, accessible intervention that empowers diverse adolescents to enter adulthood with favorable CVH.

Transactions

Action Obligated Date
Amendment $193,674
Amendment $0
Amendment $0
Amendment $288,132
Amendment $3,170
Amendment $3,170
Amendment $252,992
Amendment $252,992
Original award $252,992

Subawards

Subrecipient Amount Awarded
The University Of Tennessee Dr. Angela Pfammatter is a clinical health psychologist, Senior Methodologist for the College of Education, Health, and Human Sciences, and Associate… $102,528
Northwestern University As part of the proposed study, Northwestern University will participate in Years 1-3 to perform the following tasks: 1) Lead data monitoring and statistical… $79,648
Subrecipient not on record In collaboration with PI Marma Perak at the Prime Institution, Dr. Kennedy will direct adaptation of an intervention for youth emotional concerns for… $45,466
Subrecipient not on record $35,593
The University Of Tennessee Dr. Pfammatter has led scientific teams conducting NIH, DOD, and industry supported clinical trials for over 15 years. She has published many peer-reviewed… $76,154
Northwestern University As part of the proposed study, Northwestern University will participate in Years 1-3 to perform the following tasks: 1) Lead data monitoring and statistical… $45,160

Quick answers

Who received award R34HL171722?

R34HL171722 was awarded to ANN & Robert H Lurie Childrens Hospital Of Chicago by National Heart Lung and Blood Institute (National Institutes of Health) on March 1, 2024.

How much is award R34HL171722 worth?

$1,247,122 has been obligated on R34HL171722.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login